Summary:
Mismatches between donor and recipient for human platelet antigens (HPA) may affect the success of transplantation due to: (a) serving as minor histocompa-tibility antigens and therefore render recipients at risk for graft-versus-host disease (GvHD), (b) inhibition of thrombopoiesis due to platelet antibodies. We therefore evaluated the occurrence of GvHD and need of platelet support by prospective analysis of donor–recipient pairs (n=53) for HPA-1, -2, -3, and -5 allotypes and screening for platelet antibodies prior to transplantation and in weekly intervals until day 100 after transplantation. Neither the incidence of GvHD nor the onset of thrombopoiesis, nor the CCI after platelet transfusions, nor the frequency of platelet transfusions was affected by HPA mismatches. Settings of homozygous donors vs heterozygous recipients or homozygous recipients vs heterozygous donors were not associated with any adverse effects on the outcome of the transplantation. Thus, the HPA-match does not affect the success of transplantation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Benjamin RJ, Mc Gurk S, Ralston MS et al. ABO incompati-bility as an adverse risk factor for survival after allogeneic bone marrow transplantation. Transfusion 1999; 39: 179–197.
Rowley SD, Liang PS, Ulz L . Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components. Bone Marrow Transplant 2000; 26: 749–757.
Worel N, Greinix HT, Schneider B et al. Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems. Transfusion 2000; 40: 543–550.
Goulmy E . Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immuno-therapy. Immunol Rev 1997; 157: 124–140.
Bussel JB, Kunicki TJ, Michelson AD . Platelets: new understanding of platelet glycoproteins and their role in disease. In: American Society for Hematology. Hematology, Education Program BookPlease place editors. 2000, pp 222–240.
Santoso S, Kiefel V . Human platelet alloantigens. Wien Klin Wochenschr 2001; 113: 806–813.
Sperr WR, Huber K, Roden M et al. Inherited platelet glycoprotein polymorphisms and a risk for coronary heart disease in young central Europeans. Thromb Res 1998; 90: 117–123.
Santoso J, Kunicki TJ, Kroll H et al. Association of the platelet glycoprotein Ia C807 T gene polymorphism with nonfatal myocardial infarction in younger patients. Blood 1999; 93: 2449–2453.
Anvari A, Janisiw M, Turel Z et al. Platelet glycoprotein Ia gene dimorphism alpha 2-807 in malignant arrhythmia in coronary artery disease. Thromb Res 2000; 98: 281–286.
Juji T, Watanabe Y, Ishikawa Y et al. Human platelet alloantigen (HPA)-5a/b mismatch decreases disease-free survival in unrelated bone marrow transplantation. Tissue Antigens 1999; 54: 229–234.
Panzer S, Kiefel V, Bartram CR et al. Immune thrombocytopenia more than a year after allogeneic marrow transplantation due to antibodies against donor platelets with anti-PlA1 specificity: evidence for a host-derived immune reaction. Br J Haematol 1989; 71: 259–264.
Bierling P, Pignon JM, Kuentz M et al. Thrombocytopenia after bone marrow transplantation caused by a recipient origin Br(a) allo-antibody: presence of mixed chimerism 3 years after the graft without hematologic relapse. Blood 1994; 83: 274–279.
Klüter H, Fehlau K, Panzer S et al. Rapid typing for human platelet antigen systems-1, -2, -3, and-5 by PCR amplification with sequence-specific primers. Vox Sang 1996; 71: 121–125.
Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C . Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood 1987; 70: 1722–1726.
Kurz M, Knoebl P, Kalhs P et al. Platelet-reactive HLA antibodies associated with low post transfusion platelet increments: a comparison between the monoclonal antibody-specific immobilization of platelet antigens assay and the lymphocytotoxicity test. Transfusion 2001; 41: 771–774.
Platelet and granulocyte antigens and antibodies. In: Brecher ME (ed.). Technical ManualAuthor group/editors/place/publ., 14th edn, American Association of Blood Banks: Bethesda, MD, USA, p 347.
Holensteiner A, Walchshofer S, Adler A et al. Human platelet antigen gene frequencies in the Austrian population. Haemo-stasis 1995; 25: 133–136.
Leeksma OC, Giltay JC, Zandbergen-Spaargaren J et al. The platelet alloantigen Zwa or PlA1 is expressed by cultured endothelial cells. Br J Haematol 1987; 66: 369–373.
Giltay JC, Brinkmann HJM, Vlekke A et al. The platelet glycoprotein IaIIa associated Br alloantigen system is expressed by cultured endothelial cells. Br J Haematol 1990; 75: 557–560.
Wernet D, Hinnak N, Schnaidt M . Reactivation of antibodies of donor and recipient origin to platelet antigens early after allogeneic bone marrow transplantation: a case report. Br J Haematol 1994; 88: 615–617.
Taaning E, Jacobsen N, Morling N . Graft-derived anti HPA-2b production after allogeneic bone-marrow transplantation. Br J Haematol 1994; 86: 651–653.
Minchinton RM, Waters AH, Kendra J, Barrett AJ . Autoimmune thrombocytopenia acquired from an allogeneic bone-marrow graft. Lancet 1982; 2: 627–629.
Minchinton RM, Waters AH, Malpas JS et al. Platelet- and granulocyte-specific antibodies after allogeneic and autologous bone marrow grafts. Vox Sang 1984; 46: 125–135.
Leitner GC, Stiegler G, Hetz H et al. Post-transfusion purpura without detectable antibodies: their adsorption from the plasma by multiple incompatible platelet transfusions. Br J Hematol 2002; 117: 994–995.
Bizzaro N, Dianese G . Neonatal alloimmune amegakaryo-cytosis. Case report. Vox Sang 1988; 54: 112–114.
Ballem PJ, Segal GM, Stratton JR et al. Mechanism of thrombocytopenia in chronic thrombocytopenic purpura. J Clin Invest 1987; 80: 33–40.
Acknowledgements
We thank Beate Eichelberger and Daniela Koren for expert technical assistance. This work was supported in part by Grant 8647 from the Jubiläumsfonds from the Oesterreichischen National Bank.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Leitner, G., Tanzmann, A., Stiegler, G. et al. Influence of human platelet antigen match on the success of stem cell transplantation after myeloablative conditioning. Bone Marrow Transplant 32, 821–824 (2003). https://doi.org/10.1038/sj.bmt.1704222
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704222